MTHFR Gene Test in Australia

What an MTHFR test is

MTHFR testing reads the DNA sequence at two well-studied positions in the MTHFR gene and reports which version of the gene you inherited from each parent.

MTHFR stands for methylenetetrahydrofolate reductase, an enzyme that converts one form of folate into 5-methyltetrahydrofolate, the form the body uses to convert homocysteine back into methionine. Two single-letter changes in the gene are common enough to be worth naming: C677T and A1298C.

You carry two copies of every gene. For C677T that means you are either wild type (no copies of the variant), heterozygous (one copy) or homozygous (two copies). Laboratory studies suggest the homozygous C677T genotype produces an enzyme with roughly 30–40% of typical activity at body temperature, and the heterozygous state around 60–70%. The A1298C variant has a smaller measured effect, and the two variants are sometimes reported together as a 'compound' genotype.

The single most important framing point: these are common variants, not a rare disease. Roughly half of people of European ancestry carry at least one copy of C677T, and something on the order of one in ten is homozygous. A finding shared with a tenth of the population is a description of normal human variation, not a diagnosis.

This also means the result cannot change. Unlike homocysteine, B12 or ferritin, your genotype is fixed at conception. There is no benefit to repeating the test, and no diet, supplement or lifestyle change alters the answer — only its downstream consequences, if any, are modifiable.

MTHFR testing became commercially popular well beyond what the underlying science supports, partly through direct-to-consumer genetic testing companies and wellness marketing that attributed a long list of unrelated symptoms — anxiety, chronic fatigue, recurrent miscarriage, autism — to this single polymorphism. Mainstream Australian medical bodies have pushed back on that framing, and this page reflects their position rather than the marketing one.

Why MTHFR is tested — and why it often is not

MTHFR genotyping is occasionally used to help explain a persistently raised homocysteine level, but Australian guidance discourages it as a routine test in healthy people.

The clinically defensible use is narrow: when homocysteine is unexplainedly elevated after nutritional and renal causes have been considered, knowing the genotype can complete the picture. Some metabolic and haematology services also consider it in specific inherited-disease work-ups, and it occasionally appears in fertility clinic panels, though its value there is contested.

Outside those settings, Australian professional bodies have been consistent and blunt. The RACGP and Choosing Wisely Australia have both cautioned against routine MTHFR genotyping, on the basis that the result rarely changes management. Testing for thrombophilia risk is a particular example — MTHFR genotype is no longer regarded as a useful predictor of venous thromboembolism, and a positive result does not on its own justify anticoagulation, aspirin or altered contraceptive or pregnancy management.

The reason is straightforward. Even in a homozygous carrier, adequate folate intake largely compensates for the reduced enzyme efficiency. What matters functionally is the homocysteine, B12 and folate result — the numbers that describe how the pathway is actually performing today. If those are normal, the genotype has little to add, and it cannot be used to predict future disease with any precision.

We think it is more useful to you to say this plainly than to sell a test that is unlikely to change what you or your doctor do next. If your real question is about fatigue, mood, fertility planning or unexplained symptoms, the tests more likely to help are homocysteine, B12, folate and a standard metabolic screen — not your fixed genetic code.

• Reasonable: persistently raised homocysteine after other causes have been assessed by a doctor.
• Reasonable: as part of a specialist-directed metabolic or haematology work-up.
• Not supported: routine screening of healthy adults.
• Not supported: as a stand-alone predictor of clotting risk, miscarriage risk or cardiovascular disease.

What a homozygous or heterozygous result means

Carrying one or two copies of C677T means the MTHFR enzyme works somewhat less efficiently — it does not mean you have a disease, and in the presence of adequate folate the practical effect is usually small.

Homozygous C677T carriers have, on average, modestly higher homocysteine levels than non-carriers, and the difference is most pronounced when folate intake is low. In populations with folate-fortified food supplies — Australia has mandated folic acid fortification of bread-making flour since 2009 — the average difference narrows considerably, which is one reason routine testing is now considered less useful here than it may once have appeared.

Heterozygous carriers show a smaller effect again, and for most people it is not detectable in their blood results at all. Compound states (one copy of C677T plus one copy of A1298C) are sometimes reported and are generally treated as intermediate between wild type and homozygous.

A positive result should not be treated as a reason to start high-dose supplementation on your own. Very high folic acid intake can mask a coexisting B12 deficiency, delaying diagnosis of a condition that can cause permanent nerve damage if left untreated. The specific 'methylated' or 'activated' folate supplement forms marketed heavily to MTHFR carriers have not been shown in good-quality trials to outperform ordinary folate in people with adequate status. Any decision about supplementation belongs with your GP, informed by your actual homocysteine, B12 and folate results — not by genotype alone.

It is also worth knowing that a homozygous result is not, on its own, a reason to change plans around pregnancy, contraception or travel. Those decisions should be made with your GP based on your overall clinical picture.

What a wild-type (negative) result means

A wild-type result means you carry no copies of the tested variants, so MTHFR is not contributing to any elevation in your homocysteine.

This is genuinely useful information in one narrow situation: if your homocysteine is raised and your genotype is wild type, the cause lies elsewhere — most often B12 or folate deficiency, kidney function, thyroid status, a medicine, or lifestyle factors such as heavy smoking or alcohol intake. In that scenario a wild-type MTHFR result correctly redirects the investigation.

A wild-type result does not mean your methylation pathway is functioning well, and it should not be read as a clean bill of health. MTHFR is one enzyme among many in the one-carbon cycle, and nutritional deficiency, kidney impairment or a medicine effect will impair the pathway regardless of genotype. If you want to know whether the pathway is working right now, measure homocysteine, B12 and folate directly — see our methylation test page.

In short: a negative genotype answers a narrow question (is MTHFR the explanation for an abnormal homocysteine?) and does not answer the broader one (is my methylation cycle running well?).

How Australian laboratories report MTHFR results

There is no numeric reference range for a genetic test — Australian laboratories report MTHFR results as a genotype at each tested position, usually alongside a short interpretive comment.

Tests that answer the question MTHFR usually can't

If MTHFR is on your mind because of fatigue, fertility planning or an unexplained symptom, these are the tests Australian doctors more often use to actually investigate it.

MTHFR is not included in any FORM Australia panel by default, precisely because RACGP and Choosing Wisely Australia advise against routine use. The tests below are the ones that typically carry real diagnostic weight for the concerns that prompt people to search for MTHFR testing in the first place.

• Methylation blood panel — Homocysteine, B12 and folate — the current, changeable, and far more actionable picture.
• Iron studies — A common, correctable contributor to fatigue that is often investigated alongside methylation markers.
• Thyroid function test — Thyroid disease can raise homocysteine independent of MTHFR genotype.
• Fertility blood test — For pregnancy planning questions, a broader fertility panel is more informative than genotype alone.
• Build your own Australian panel — Combine homocysteine, B12, folate and thyroid function in a single blood draw.

What affects an MTHFR result — and what does not

Nothing affects your genotype after conception. What varies is how much your genotype actually matters, which depends on your folate intake, kidney function and overall diet.

This is the one section on this page where the usual list of confounders — illness, hydration, timing, medicines — genuinely does not apply. Your MTHFR genotype is set at conception and cannot be changed by diet, supplements, exercise, illness or time of day. A sample collected fasting or fed, morning or evening, unwell or well, will always give the same answer.

What does vary is whether the genotype has any measurable downstream effect. Folate-replete diets — which most Australians now have, given mandatory folic acid fortification of bread-making flour since 2009 — substantially blunt the effect of even a homozygous genotype on homocysteine. Alcohol, smoking, kidney function, thyroid status and B12 intake all influence homocysteine directly, independent of genotype, and typically outweigh it.

Because there is nothing to prepare for and nothing that changes the result, MTHFR testing is unusual among the tests on this site in requiring no collection instructions beyond a standard blood draw.

Who should consider testing

MTHFR testing is worth considering when a doctor is investigating an unexplained raised homocysteine, and rarely otherwise.

If your goal is to understand how your folate and B12 metabolism is actually performing, a methylation blood panel measuring homocysteine, B12 and folate answers that question directly, changes with treatment, and can be repeated — unlike a genotype that never changes.

• People with a persistently elevated homocysteine after B12, folate, thyroid and kidney causes have been assessed.
• People undergoing a specialist metabolic or haematology work-up where the genotype has been requested.
• People who want the result for completeness and understand it will most likely not change anything.

How testing works with FORM in Australia

You choose the test, we issue an Australian pathology request form, you walk in for collection at an accredited centre, and you receive your genotype with a written plain-English explanation of what it does and does not mean.

• No referral from your own GP is required. Privately requested pathology is arranged under a request from a registered medical practitioner working with our accredited lab partner.
• Collection is a walk-in at Laverty (Healius) pathology centres, which operate in every Australian state and territory (NATA / ISO 15189 accredited).
• Results are returned in Australian SI units against the performing laboratory's own reference intervals, with a written, plain-English explanation.
• FORM is a diagnostic blood-testing service. We do not prescribe, supply or manage medicines — take your results to your GP or another registered Australian doctor.
• Australian ordering is currently pre-sale. Join the waitlist and we will let you know the moment it opens.
• No fasting and no preparation — genotype is unaffected by diet, medicines or timing.
• Genetic results carry particular privacy considerations; we recommend discussing them with your GP, especially if you are considering telling family members.